The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.76 in the prior trading day, Icecure Medical Ltd (NASDAQ: ICCM) closed at $0.75, down -2.35%. In other words, the price has decreased by -$2.35 from its previous closing price. On the day, 0.49 million shares were traded. ICCM stock price reached its highest trading level at $0.775 during the session, while it also had its lowest trading level at $0.725.
Ratios:
Our goal is to gain a better understanding of ICCM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICCM now has a Market Capitalization of 51489684 and an Enterprise Value of 40821888. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.39 while its Price-to-Book (P/B) ratio in mrq is 15.45. Its current Enterprise Value per Revenue stands at 14.647 whereas that against EBITDA is -2.626.
Stock Price History:
The Beta on a monthly basis for ICCM is 1.34, which has changed by -0.089024365 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, ICCM has reached a high of $1.63, while it has fallen to a 52-week low of $0.52. The 50-Day Moving Average of the stock is -22.19%, while the 200-Day Moving Average is calculated to be -30.55%.
Shares Statistics:
The stock has traded on average 1.71M shares per day over the past 3-months and 514410 shares per day over the last 10 days, according to various share statistics. A total of 59.82M shares are outstanding, with a floating share count of 34.23M. Insiders hold about 50.17% of the company’s shares, while institutions hold 0.36% stake in the company. Shares short for ICCM as of 1760486400 were 1554321 with a Short Ratio of 0.91, compared to 1757894400 on 577276. Therefore, it implies a Short% of Shares Outstanding of 1554321 and a Short% of Float of 10.95.
Earnings Estimates
A comprehensive evaluation of Icecure Medical Ltd (ICCM) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.2 and -$0.23 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.17, with 3.0 analysts recommending between -$0.06 and -$0.23.
Revenue Estimates
3 analysts predict $626k in revenue for. The current quarter. It ranges from a high estimate of $828k to a low estimate of $450k. As of. The current estimate, Icecure Medical Ltd’s year-ago sales were $662kFor the next quarter, 3 analysts are estimating revenue of $1.45M. There is a high estimate of $2.5M for the next quarter, whereas the lowest estimate is $650k.
A total of 3 analysts have provided revenue estimates for ICCM’s current fiscal year. The highest revenue estimate was $4.33M, while the lowest revenue estimate was $2.35M, resulting in an average revenue estimate of $3.32M. In the same quarter a year ago, actual revenue was $3.29MBased on 3 analysts’ estimates, the company’s revenue will be $12.28M in the next fiscal year. The high estimate is $26.36M and the low estimate is $5.08M.
